Richard E. Engler

1 week ago | mondaq.com | Richard E. Engler |Carla N. Hutton

BC Bergeson & Campbell More Bergeson & Campbell, P.C. is a Washington D.C. law firm focusing on chemical product approval and regulation, product defense, and associated business issues. The Acta Group, B&C's scientific and regulatory consulting affiliate provides strategic, comprehensive support for global chemical registration, regulation, and sustained compliance.

1 month ago | mondaq.com | Richard E. Engler |Carla N. Hutton

BC Bergeson & Campbell More Perhaps nothing is more complex in the corporate world than doing business at the intersection of science, law, and policy. Regulatory compliance, product approvals, and product defense must keep pace with scientific breakthroughs and competitive pressures.

2 months ago | natlawreview.com | Kyle Dull |Paul C. Besozzi |Lynn L. Bergeson |Richard E. Engler

February 2025 saw an important False Claims Act settlement involving allegations of known cybersecurity failures by Health Net Federal Services Inc. (HNFS), a government contractor that provides TRICARE healthcare management services to active duty military members and their families. HNFS as well as its parent corporation Centene agreed to pay just over $11 million to resolve alleged false claims submitted to the U.S. Department of Defense.

2 months ago | lexology.com | Lynn L. Bergeson |Richard E. Engler |Carla N. Hutton

On March 10, 2025, the U.S. Environmental Protection Agency (EPA) announced its intent to reconsider the May 3, 2024, rule amending the procedural framework rule for conducting risk evaluations under the Toxic Substances Control Act (TSCA) (2024 Risk Evaluation Framework Rule).